Dose based on m² [General Sta­tis­tics]

posted by VK – Russia, 2013-07-17 18:17 (4728 d 17:12 ago) – Posting: # 11000
Views: 11,380

Dear Dr_Dan,

Thank you for the prompt reply. Please let me comment below:

❝ What do you mean by "We did regular calculations"?


We calculated PK parameters (Cmax, AUClast and Cmax/AUClast), correspodning 90% CIs and ANOVA (as required in Russia) for 100% of patients.

❝ If you had choosen

❝ 70% received 4x25mg

❝ 30% received either 3x25mg or 5x25mg

❝ Then 100% of the subjects could be evaluated.


This is our case. To shed more light on the design - 70% receieved 4*500mg, while 30% received either 3*500mg or 5*500 mg. Hence the only strength was 500, while the doses were different.

So the regulatory body experts tell us that we should use 70% for the calculation because the received one dose. That is why I looking for some kind of GL/textbook I could refer our experts.

Cheers,

VK

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
381 visitors (0 registered, 381 guests [including 18 identified bots]).
Forum time: 11:30 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5